- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05431829
Urdu Version of Fonseca Anamnestic Index: Reliability and Validity Study
June 20, 2022 updated by: Riphah International University
Analysis of Psychometric Properties and Cultural Adaptation of Urdu Version of Fonseca Anamnestic Index in Pakistani Population
The aim of study is to translate and culturally adapt Fonseca Anamnestic Index into Urdu language and to investigate the reliability and validity in Pakistani population over the age 18 years.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The English version of the Fonseca Anamnestic Index will be translated and culturally adapted as per previous recommendation.
In Pakistani general population, Urdu Version of Fonseca Anamnestic Index will distributed among 140 participants choose by random sampling technique based on pre-defined inclusion and exclusion criteria.
To test inter and intra-observer reliability of the final Urdu Version of Fonseca Anamnestic Index questionnaire will be filled on the same day, by two observers, and for the Inter-Observers assessment, with an interval of 30 minute between the first and the second application.
Third assessment will carried out after 7 days by Observer-1, for intra-observer assessment.
Data will be entered and analyzed using Statistical Package of Social Sciences Version 24.
Internal consistency will be analyzed with Cronbach alpha value.
Test- re-test reliability will be assessed using an intra-class correlation coefficient.
The Urdu Version of Fonseca Anamnestic Index will be evaluated for content validity, construct validity, criterion validity and responsiveness.
Study Type
Observational
Enrollment (Anticipated)
140
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Faisalabad, Punjab, Pakistan, 38000
- Recruiting
- Ripah International University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pakistani population with or without temporo-mandibular disorders over the age 18-80 years and both genders.
Description
Inclusion Criteria:
- Patient with the age of 18 years.
- Having any previous history of temporo-mandibular joint pain
- Having any current condition of temporo-mandibular disorders.
- Both Genders are included equally.
Exclusion Criteria:
- Inability to understand or follow the instructions of the Fonseca Anamnestic Index.
- Suffering from any neurological condition.
- Suffering from any unstable medical condition.
- Patients with rheumatoid arthritis were also excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fonseca Anamnestic Index
Time Frame: 1st day
|
It is a scale proposed to identify and determine the severity of temporo-mandibular disorder through 10 question being designed in the form of a questionnaire which is then to be filled and completed by the population.
|
1st day
|
Numeric Pain Rating Scale
Time Frame: 1st day
|
The numeric pain rating scale is a self-implemented pain intensity perception scale.
In this test, all the possibilities are arranged at the same level, with 0 being the absence of pain and 10 being the maximum pain
|
1st day
|
Short Form - 36
Time Frame: 1st day
|
The Short Form - 36 which is self-administered and evaluates general quality of life from physical and emotional points of view.
It consists of 12 questions that are presented with a variable number of answers.
|
1st day
|
Dizziness Handicap Inventory
Time Frame: 1st day
|
Dizziness and vertigo sensations were measured with the dizziness handicap inventory, which is a self-implemented scale that identifies vertigo or lack of balance.
The instrument consists of 25 questions that can be answered as yes, no or sometimes.
This questionnaire identifies functional, physical and emotional problems related to balance disorders.
|
1st day
|
Headache impact Test-6
Time Frame: 1st day
|
The headache impact test is a self-administered headache questionnaire that consists of six questions with five possible answers.
The possible outcomes are "never", "rarely", "sometimes", "very often" and "always".
The numerical result is the sum of the answers.
|
1st day
|
Neck Disability Index
Time Frame: 1st day
|
The neck disability index is a questionnaire that assesses disability produced by neck pain.
It consists of ten questions with six different answers that are ordered from least to most disability, with 0 corresponding to no disability and 5 corresponding to greatest disability.
The result is the sum of the answers, ranging from 0 to 50.
|
1st day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2021
Primary Completion (Anticipated)
July 10, 2022
Study Completion (Anticipated)
July 12, 2022
Study Registration Dates
First Submitted
June 20, 2022
First Submitted That Met QC Criteria
June 20, 2022
First Posted (Actual)
June 24, 2022
Study Record Updates
Last Update Posted (Actual)
June 24, 2022
Last Update Submitted That Met QC Criteria
June 20, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-FSD-00255
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temporomandibular Disorder
-
CES UniversityCompletedTemporomandibular Disorder | Children, Only | Pain Disorder | Joint Disorder, Temporomandibular
-
University of AlcalaCompletedTemporomandibular DisorderSpain
-
University of Nove de JulhoUnknownTemporomandibular DisorderBrazil
-
Wroclaw Medical UniversityEnrolling by invitationTemporomandibular Joint Disorders | Temporomandibular Disorder | Temporomandibular Joint Osteoarthritis | Temporomandibular ArthritisPoland
-
Beirut Arab UniversityRecruitingTemporomandibular DisorderLebanon
-
Hams Hamed AbdelrahmanCompletedTemporomandibular DisorderEgypt
-
Centre Hospitalier Universitaire de NiceCompleted
-
Federal University of Rio Grande do SulCompletedTemporomandibular Disorder
-
University of Nove de JulhoCompleted
-
University of Sao PauloConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedTemporomandibular DisorderBrazil